Large Cap Biopharmaceuticals Q1 2023: In This Bullish Run Biotech Lags…Updates-2…JNJ, UNH, XLV
Update-2 4/5/23...2:20p EDT..Healthcare and other defensive groups continue to run up as concerns grow about rising rates in a slowing economy. Biopharma +2% movers:AZN, GSK, LLY, MRK,PFE, RHHBY, VRTX. UNH up 3.48% to $510,XLV up 1.79% to $133.28. SMID lagging with XBI down 0.59% to 75+; CRSP...
Biotech and Life Science Trades: Q1 2023 Performance By the Numbers
Biotech and Life Science Trades Q1 2023 By the Numbers Leading sectors in Q1 were Tech and Semis.The SPY was up 7% YTD. Small caps beginning to trend up. Healthcare lagging XLV down 5.5% as investors rotate into growth. Despite a strong month and a great finish to the quarter many strategists...
Can Healthcare Stocks Survive Macro Headwinds?…. Update-1
Update-1 3/28/23..Sector rotation continues with energy, materials leading today and healthcare, technology down slightly. Consumer confidence rises to 104.2 despite bank failures. Commodities strong.VikingTherapeutics (VKTX) rose 69% on Phase 1 data for Dua lGLP-1/GIP receptor agonist, for...
How Did Biotech Stocks Perform in this Turbulent Week? Update-2 healthcare and biopharma rally
Update-2 3/24..12;15p ..Biopharma and healthcare stocks rally. Update over weekend. ABBV AMGN BIIB GILD REGN VRTX and UNH and Medtech ISRG MDT...small caps EVH PACB. Update-1 3/22...Away from FEDspeak". We believe that sm aller cap life science stocks with good business models can outperform...
Small Cap Biotechs Slammed by SVB Collapse
Small Cap Biotechs Slammed by SVB Collapse Small Cap biotechs have been hit hard and needs time to sort out. Momentum and sentiment in a risk-off mode. Opportunity to assess good stocks for longer term after seeing how they trade. Nothing like a banking crisis to start off a weekend. But maybe...